[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Ca—A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[2]
|
Schuurman, M.S., Kruitwagen, R., Portielje, J.E.A., Roes, E.M., Lemmens, V. and Van Deraa, M.A. (2018) Treatment and Outcome of Elderly Patients with Advanced Stage Ovarian Cancer: A Nationwide Analysis. Gynecologic Oncology, 149, 270-274. https://doi.org/10.1016/j.ygyno.2018.02.017
|
[3]
|
Kaiser, J. and Couzin-Frankel, J. (2018) Cancer Immunotherapy Sweeps Nobel for Medicine. Science (New York, NY), 362, 13. https://doi.org/10.1126/science.362.6410.13
|
[4]
|
薛春燕, 谢荃沁, 徐云, 等. PD-L1和PD-L2在卵巢癌组织中的表达及对患者预后判断的价值[J]. 现代免疫学, 2020, 40(1): 1-8.
|
[5]
|
Akkin, S., Varan, G. and Bilensoy, E. (2021) A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers. Molecules (Basel, Switzerland), 26, Article No. 3382. https://doi.org/10.3390/molecules26113382
|
[6]
|
Gillies, R.J., Anderson, A.R., Gatenby, R.A., et al. (2010) The Biology Underlying Molecular Imaging in Oncology: From Genome to Anatome and Back Again. Clinical Radiology, 65, 517-521. https://doi.org/10.1016/j.crad.2010.04.005
|
[7]
|
Khorrami, M., Prasanna, P., Gupta, A., et al. (2020) Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non-Small Cell Lung Cancer. Cancer Immunology Research, 8, 108-119. https://doi.org/10.1158/2326-6066.CIR-19-0476
|
[8]
|
Wu, J., Mayer, A.T. and Li, R. (2022) Integrated Imaging and Molecular Analysis to Decipher Tumor Microenvironment in the Era of Immunotherapy. Seminars in Cancer Biology, 84, 310-328. https://doi.org/10.1016/j.semcancer.2020.12.005
|
[9]
|
Xiong, S. and Tang, K. (2022) A Diagnostic Dilemma of a Pulmonary Nodule of a Patient Who Suffered Advanced Ovarian Cancer: A Case Report and a Hypothesis. International Journal of Surgery Case Reports, 94, Article ID: 107111. https://doi.org/10.1016/j.ijscr.2022.107111
|
[10]
|
孟靖涵, 何秀丽. IOTA SR与CA125、HE4、ROMA、RMI1、GI-RADS对卵巢良恶性肿瘤的诊断价值比较[J]. 中国实用妇科与产科杂志, 2021, 37(1): 100-104.
|
[11]
|
Ferreira-Junior, J.R., Koenigkam-Santos, M., Magalhães Tenório, A.P., et al. (2020) CT-Based Radiomics for Prediction of Histologic Subtype and Metastatic Disease in Primary Malignant Lung Neoplasms. International Journal of Computer Assisted Radiology and Surgery, 15, 163-172. https://doi.org/10.1007/s11548-019-02093-y
|
[12]
|
Li, S., Liu, J., Xiong, Y., et al. (2022) Application Values of 2d and 3d Radiomics Models Based on Ct Plain Scan in Differentiating Benign from Malignant Ovarian Tumors. BioMed Research International, 2022, Article ID: 5952296. https://doi.org/10.1155/2022/5952296
|
[13]
|
Yao, F., Ding, J., Lin, F., et al. (2022) Nomogram Based on Ultrasound Radiomics Score and Clinical Variables for Predicting Histologic Subtypes of Epithelial Ovarian Cancer. The British Journal of Radiology, 95, Article ID: 20211332. https://doi.org/10.1259/bjr.20211332
|
[14]
|
Sato, S. and Itamochi, H. (2014) Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: Latest Results and Place in Therapy. Therapeutic Advances in Medical Oncology, 6, 293-304. https://doi.org/10.1177/1758834014544891
|
[15]
|
Sehouli, J. and Grabowski, J.P. (2017) Surgery for Recurrent Ovarian Cancer: Options and Limits. Best Practice & Research Clinical Obstetrics & Gynaecology, 41, 88-95. https://doi.org/10.1016/j.bpobgyn.2016.10.009
|
[16]
|
Nougaret, S., Sadowski, E., Lakhman, Y., et al. (2022) The BUMPy Road of Peritoneal Metastases in Ovarian Cancer. Diagnostic and Interventional Imaging, 103, 448-459. https://doi.org/10.1016/j.diii.2022.05.003
|
[17]
|
Gerestein, C.G., Eijkemans, M.J., Bakker, J., et al. (2011) Nomogram for Suboptimal Cytoreduction at Primary Surgery for Advanced Stage Ovarian Cancer. Anticancer Research, 31, 4043-4049.
|
[18]
|
Lorusso, D., Sarno, I., Di Donato, V., et al. (2014) Is Postoperative Computed Tomography Evaluation a Prognostic Indicator in Patients with Optimally Debulked Advanced Ovarian Cancer? Oncology, 87, 293-299. https://doi.org/10.1159/000365357
|
[19]
|
Weinberger, V., Fischerova, D., Semeradova, I., et al. (2016) Prospective Evaluation of Ultrasound Accuracy in the Detection of Pelvic Carcinomatosis in Patients with Ovarian Cancer. Ultrasound in Medicine & Biology, 42, 2196-2202. https://doi.org/10.1016/j.ultrasmedbio.2016.05.014
|
[20]
|
Zikan, M., Fischerova, D., Semeradova, I., et al. (2017) Accuracy of Ultrasound in Prediction of Rectosigmoid Infiltration in Epithelial Ovarian Cancer. Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 50, 533-538. https://doi.org/10.1002/uog.17363
|
[21]
|
Gupta, A., Jha, P., Baran, T.M., et al. (2022) Ovarian Cancer Detection in Average-Risk Women: Classic-versus Nonclassic-Appearing Adnexal Lesions at Us. Radiology, 303, 603-610. https://doi.org/10.1148/radiol.212338
|
[22]
|
Jha, P., Gupta, A., Baran, T.M., et al. (2022) Diagnostic Performance of the Ovarian-Adnexal Reporting and Data System (O-Rads) Ultrasound Risk Score in Women in the United States. JAMA Network Open, 5, E2216370. https://doi.org/10.1001/jamanetworkopen.2022.16370
|
[23]
|
Antil, N., Wang, H., Kaffas, A.E., et al. (2023) In Vivo Ultrasound Molecular Imaging in the Evaluation of Complex Ovarian Masses: A Practical Guide to Correlation with ex Vivo Immunohistochemistry. Advanced Biology, 7, E2300091. https://doi.org/10.1002/adbi.202300091
|
[24]
|
Willmann, J.K., Bonomo, L., Testa, A.C., et al. (2017) Ultrasound Molecular Imaging with Br55 in Patients with Breast and Ovarian Lesions: First-in-Human Results. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 35, 2133-2140. https://doi.org/10.1200/JCO.2016.70.8594
|
[25]
|
Fang, J., Zhao, W., Li, Q., et al. (2020) Correlation Analysis of Conventional Ultrasound Characteristics and Strain Elastography with Ki-67 Status in Breast Cancer. Ultrasound in Medicine & Biology, 46, 2972-2978. https://doi.org/10.1016/j.ultrasmedbio.2020.06.024
|
[26]
|
Jin, X., Ai, Y., Zhang, J., et al. (2020) Noninvasive Prediction of Lymph Node Status for Patients with Early-Stage Cervical Cancer Based on Radiomics Features from Ultrasound Images. European Radiology, 30, 4117-4124. https://doi.org/10.1007/s00330-020-06692-1
|
[27]
|
Nero, C., Ciccarone, F., Boldrini, L., et al. (2020) Germline BRCA 1-2 Status Prediction through Ovarian Ultrasound Images Radiogenomics: A Hypothesis Generating Study (PROBE Study). Scientific Reports, 10, Article No. 16511. https://doi.org/10.1038/s41598-020-73505-2
|
[28]
|
Moro, F., Giudice, M.T., Bolomini, G., et al. (2023) Imaging in Gynecological Disease: Clinical and Ultrasound Characteristics of Recurrent Ovarian Stromal Cell Tumors. Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology.
|
[29]
|
Yao, F., Ding, J., Hu, Z., et al. (2021) Ultrasound-Based Radiomics Score: A Potential Biomarker for the Prediction of Progression-Free Survival in Ovarian Epithelial Cancer. Abdominal Radiology (New York), 46, 4936-4945. https://doi.org/10.1007/s00261-021-03163-z
|
[30]
|
Rundo, F., Banna, G.L., Prezzavento, L., et al. (2020) 3D Non-Local Neural Network: A Non-Invasive Biomarker for Immunotherapy Treatment Outcome Prediction. Case-Study: Metastatic Urothelial Carcinoma. Journal of Imaging, 6, Article No. 133. https://doi.org/10.3390/jimaging6120133
|
[31]
|
Yin, X., Liao, H., Yun, H., et al. (2022) Artificial Intelligence-Based Prediction of Clinical Outcome in Immunotherapy and Targeted Therapy of Lung Cancer. Seminars in Cancer Biology, 86, 146-159. https://doi.org/10.1016/j.semcancer.2022.08.002
|
[32]
|
高境泽, 吴霞. 卵巢癌组织中CXCR3表达与免疫细胞浸润的相关性研究[J]. 现代免疫学, 2021, 41(3): 177-183.
|
[33]
|
Yang, M., Lu, J., Zhang, G., et al. (2021) CXCL13 Shapes Immunoactive Tumor Microenvironment and Enhances the Efficacy of PD-1 Checkpoint Blockade in High-Grade Serous Ovarian Cancer. Journal for Immunotherapy of Cancer, 9, e001136. https://doi.org/10.1136/jitc-2020-001136
|
[34]
|
Brenna, E. and Pedroza-Pacheco, I. (2022) Harnessing CXCL13 in Ovarian Cancer. Nature Reviews Immunology, 22, Article No. 145. https://doi.org/10.1038/s41577-022-00683-7
|
[35]
|
Xu, W., Zhu, C., Ji, D., et al. (2023) CT-Based Radiomics Prediction of CXCL13 Expression in Ovarian Cancer. Medical Physics, 50, 6801-6814. https://doi.org/10.1002/mp.16730
|
[36]
|
Wan, S., Zhou, T., Che, R., et al. (2023) CT-Based Machine Learning Radiomics Predicts CCR5 Expression Level and Survival in Ovarian Cancer. Journal of Ovarian Research, 16, Article No. 1. https://doi.org/10.1186/s13048-022-01089-8
|
[37]
|
姚晋, 闵鹏秋, 黄娟. 腹膜转移瘤的CT征象[J]. 中国普外基础与临床杂志, 2005, 12(6): 620-623.
|
[38]
|
Ahrens, E.T. and Bulte, J.W. (2013) Tracking Immune Cells in Vivo Using Magnetic Resonance Imaging. Nature Reviews Immunology, 13, 755-763. https://doi.org/10.1038/nri3531
|
[39]
|
Taylor, E.N., Wilson, C.M., Franco, S., et al. (2022) Monitoring Therapeutic Responses to Silicified Cancer Cell Immunotherapy Using Pet/Mri in a Mouse Model of Disseminated Ovarian Cancer. International Journal of Molecular Sciences, 23, Article ID: 10525. https://doi.org/10.3390/ijms231810525
|
[40]
|
Bouchlaka, M.N., Ludwig, K.D., Gordon, J.W., et al. (2016) (19)F-MRI for Monitoring Human NK Cells in Vivo. Oncoimmunology, 5, E1143996. https://doi.org/10.1080/2162402X.2016.1143996
|
[41]
|
Zhang, H., Mao, Y., Chen, X., et al. (2019) Magnetic Resonance Imaging Radiomics in Categorizing Ovarian Masses and Predicting Clinical Outcome: A Preliminary Study. European Radiology, 29, 3358-3371. https://doi.org/10.1007/s00330-019-06124-9
|
[42]
|
Cadour, F., Cautela, J., Rapacchi, S., 等. 免疫检查点抑制剂性心肌炎的心脏MRI表现及预后价值[J]. 国际医学放射学杂志, 2022, 45(4): 481.
|
[43]
|
Aide, N., Hicks, R.J., Le Tourneau, C., et al. (2019) FDG PET/CT for Assessing Tumour Response to Immunotherapy: Report on the EANM Symposium on Immune Modulation and Recent Review of the Literature. European Journal of Nuclear Medicine and Molecular Imaging, 46, 238-250. https://doi.org/10.1007/s00259-018-4171-4
|
[44]
|
(2020) Expert Consensus on Assessing Tumor Response to Immune Checkpoint Inhibitors by PET/CT (2020 Edition). Chinese Journal of Oncology, 42, 697-705.
|
[45]
|
Kaira, K., Higuchi, T., Naruse, I., et al. (2018) Metabolic Activity by (18)F-FDG-PET/CT Is Predictive of Early Response after Nivolumab in Previously Treated NSCLC. European Journal of Nuclear Medicine and Molecular Imaging, 45, 56-66. https://doi.org/10.1007/s00259-017-3806-1
|
[46]
|
李敏, 李绪清, 颜士杰, 等. 18F-脱氧葡萄糖PET/CT联合CA125在诊断卵巢癌复发转移中的应用价值[J]. 重庆医科大学学报, 2017, 42(12): 1635-1638.
|
[47]
|
Wang, X., Xu, C., Grzegorzek, M., et al. (2022) Habitat Radiomics Analysis of Pet/Ct Imaging in High-Grade Serous Ovarian Cancer: Application to Ki-67 Status and Progression-Free Survival. Frontiers in Physiology, 13, Article ID: 948767. https://doi.org/10.3389/fphys.2022.948767
|
[48]
|
Mu, W., Jiang, L., Shi, Y., et al. (2021) Non-Invasive Measurement of PD-L1 Status and Prediction of Immunotherapy Response Using Deep Learning of PET/CT Images. Journal for Immunotherapy of Cancer, 9, e002118. https://doi.org/10.1136/jitc-2020-002118
|
[49]
|
Mapelli, P., Incerti, E., Fallanca, F., et al. (2016) Imaging Biomarkers in Ovarian Cancer: The Role of 18F-FDG PET/CT. The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 60, 93-102.
|
[50]
|
Peng, H., Dong, D., Fang, M.J., et al. (2019) Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 25, 4271-4279. https://doi.org/10.1158/1078-0432.CCR-18-3065
|